Percutaneous coronary intervention in patients with atrial fibrillation: current state of the problem and therapeutic strategies
Objective: To study the efficacy and safety of current antithrombotic strategies, the role of functional assessment and intravascular imaging, and the impact of comorbidity on the outcomes of percutaneous coronary intervention in patients with atrial fibrillation. Materials and Methods: This review article analyzes the results of randomized clinical trials, systematic literature reviews, and meta-analyses covering randomized and observational studies from 2021 to 2025. Results: Approximately 20-30% of patients with atrial fibrillation will require percutaneous coronary intervention (PCI) during their lifetime. Of these, approximately 12% already have concomitant atrial fibrillation, which requires a careful balance between antithrombotic and anticoagulant therapy.
Сведения
- Опубликовано
- 2026 · Т. 7, № 2, С. 175-186
- Язык
- Английский
- ISSN
- 2707-5265
- Издатель
- Ассоциация общественного здравоохранения Таджикистана
- Аффилиации
- Department of Therapy and Cardiorheumatology, State Educational Institution "Institute of Postgraduate Education in Healthcare of the Republic of Tajikistan", Dushanbe, Tajikistan